Global RNA sequencing Market Report is
a professional and in-depth research report on the world’s major regional
market conditions of the market, focusing on the main regions and the main
countries (North America, Europe, APAC, MEA and South America). The report
focuses on leading industry players with information such as company profiles,
products and services offered, financial information of last 3 years, key
development in past five years.
RNA sequencing or whole transcriptome shotgun sequencing is a
process to identify the presence and quantity of RNA present in a biological
sample. It enables to analyze the constantly changing cellular transcriptome;
identifies gene fusion, post transcriptional modifications, & splicing; and
recognizes the exon/intron boundary of the eukaryotic genes.
Advancements of in sequencing technology, increase in acceptance
of NGS technology, and growth in number of partnerships & collaborations
drive the growth of the global RNA sequencing market. However, dearth of
skilled professionals and problems associated with storage of sequencing data
restrain the market growth. Government initiatives in population sequencing and
emerging markets such as China & India offer significant growth
opportunities for the market growth.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2980
The market is dominated by players such as
·
Affymetrix Inc.
·
Thermo Fisher Scientific Inc.
·
Agilent Technologies Inc.
·
Bio-Rad Laboratories Inc.
·
GE Healthcare
·
Illumina Inc.
·
Qiagen N.V.
·
F. Hoffmann-La Roche Ltd.
·
Sigma Aldrich
·
Fluidigm Corporation
The RNA sequencing market in segmented on the basis of products
& services, technology, application, end user, and region. Based on
products & services, the market is categorized into sample preparation,
sequencing platforms & consumables for RNA sequencing; RNA sequencing
services; and data analysis, storage, and management. Sample preparation is
subsegmented into application and method.
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/2980
Based on technology, the market is classified into sequencing by
synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT)
sequencing, and nanopore sequencing. Applications covered in the study include
de novo transcriptome assembly, expression profiling analysis, variant calling
& transcriptome epigenetics, and small RNA sequencing.
According to end user, the market is divided into research
centers and academic & government institutes, hospitals & clinics,
pharmaceutical & biotechnology companies, and others (nonprofit
organizations, agrigenomics organizations, and consumer genomics companies).
Geographically, it is analyzed across North America (U.S., Canada, and Mexico),
Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific
(Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and
LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2980
Key Benefits
- The study provides an in-depth analysis
of the market with current trends and future estimations to elucidate the
imminent investment pockets.
- Comprehensive analysis of all
geographical regions is provided, which helps to determine the prevailing
opportunities.
- Key players are profiled and their
strategies are analyzed thoroughly, which help to understand competitive
outlook of the global market.
- The report offers a quantitative analysis
from 2017 to 2023, which is expected to enable the stakeholders to
capitalize on prevailing market opportunities.
- Exhaustive analysis of the RNA sequencing
market by type helps to understand the types of sequencing technologies
that are currently being used along with the variants that are expected to
gain prominence in the future.
Access Full Summery @ https://www.alliedmarketresearch.com/rna-sequencing-market
No comments:
Post a Comment